Checkmate Pharmaceuticals Inc

NASDAQ:CMPI   2:41:38 PM EDT
10.47
+0.02 (+0.14%)
Earnings Announcements

Checkmate Pharmaceuticals Announces Q1 2022 Results And Provides Business Update

Published: 05/12/2022 21:27 GMT
Checkmate Pharmaceuticals Inc (CMPI) - Checkmate Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business Update.
Checkmate Pharmaceuticals Inc Qtrly Loss per Share $0.73.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.75

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.75

More details on our Analysts Page.